Koshinski Asset Management
ANVS icon

Koshinski Asset Management’s Annovis Bio ANVS Stock Holding History

Koshinski Asset Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,028
Closed -$33.5K – 770
2026
Q1 		$33.5K Buy
15,028
+18
+0.1% +$49 ﹤0.01% 727
2025
Q4 		$51.9K Buy
+15,010
New +$45.1K ﹤0.01% 713
2023
Q4 		– Sell
-15,000
Closed -$142K – 508
2023
Q3 		$142K Hold
15,000
– – 0.02% 545
2023
Q2 		$214K Hold
15,000
– – 0.02% 542
2023
Q1 		$231K Buy
15,000
+5,000
+50% +$80.7K 0.02% 495
2022
Q4 		$134K Hold
10,000
– – 0.01% 579
2022
Q3 		$137K Hold
10,000
– – 0.02% 522
2022
Q2 		$113K Buy
+10,000
New +$109K 0.01% 577

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Koshinski Asset Management's ANVS Position: Q2 2026 in Review

Koshinski Asset Management sold out of Annovis Bio (ANVS) in Q2 2026, closing a stake of 15,028 shares — an estimated $33.5K sold.

Koshinski Asset Management first reported a position in ANVS in Q2 2022 and held it in 8 quarters. The position peaked at $231K in Q1 2023. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Koshinski Asset Management reported no remaining Annovis Bio position as of Q2 2026 after selling out during the quarter.
  • Koshinski Asset Management sold 15,028 Annovis Bio shares in Q2 2026, an estimated $33.5K.
  • Koshinski Asset Management first reported a position in Annovis Bio in Q2 2022 and held it in 8 quarters.
  • Koshinski Asset Management's Annovis Bio position peaked at $231K in Q1 2023.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.